Research Identifies Serotonergic Circuit's Role in Tinnitus, Impacting SSRI Use
Recent research conducted by Oregon Health & Science University and Anhui University in China has uncovered a specific serotonergic circuit in the brain that plays a crucial role in the development of tinnitus. This study, published in the Proceedings of the National Academy of Sciences, reveals that elevated levels of serotonin, a neurotransmitter commonly increased by Selective Serotonin Reuptake Inhibitors (SSRIs) used to treat depression and anxiety, can exacerbate or even induce tinnitus. Tinnitus is characterized by a persistent ringing or buzzing in the ears, affecting up to 14% of the global population. The researchers used a mouse model to demonstrate that increased serotonin levels lead to heightened tinnitus symptoms, providing direct evidence of the involvement of 5-HT neurons in the dorsal raphe nucleus in this condition. 
